Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Ani Pharmaceuticals (ANIP) over the last 16 years, with Dec 2024 value amounting to $18.0 million.

  • Ani Pharmaceuticals' Prepaid Assets rose 6.16% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 6.16%. This contributed to the annual value of $18.0 million for FY2024, which is 3.30% up from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' Prepaid Assets is $18.0 million, which was up 3.30% from $17.4 million recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Prepaid Assets ranged from a high of $18.0 million in FY2024 and a low of $5.9 million during FY2020.
  • Moreover, its 3-year median value for Prepaid Assets was $17.4 million (2023), whereas its average is $14.6 million.
  • Data for Ani Pharmaceuticals' Prepaid Assets shows a peak YoY spiked of 107.46% (in 2023) over the last 5 years.
  • Over the past 5 years, Ani Pharmaceuticals' Prepaid Assets (Yearly) stood at $5.9 million in 2020, then climbed by 29.48% to $7.6 million in 2021, then grew by 10.52% to $8.4 million in 2022, then soared by 107.46% to $17.4 million in 2023, then grew by 3.30% to $18.0 million in 2024.